METASTATIC BILIARY TRACT CARCINOMA
Clinical trials for METASTATIC BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost bile duct cancer treatment
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug emavusertib to standard chemotherapy and immunotherapy can improve outcomes for people with advanced bile duct or gallbladder cancer that has not been treated before. The study will enroll about 48 participants to …
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Morning vs. afternoon: can timing boost cancer immunotherapy?
Symptom relief Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon changes how well it fights advanced or metastatic solid tumors. Researchers believe the body's internal clock (circadian rhythm) might affect immune response. About 160 adults with certain cancers like …
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 16, 2026 23:47 UTC